granules-india-files-paragraph-iv-certification-for-ruxolitinib-er-tablets News in Hindi -1 News Headlines Found

Granules India files Paragraph IV certification for Ruxolitinib ER tablets

Hyderabad, Oct 7 (UNI) Granules India Ltd on Wednesday announced that it has submitted a Paragraph IV certification in connection with its abbreviated new drug application (ANDA) for Ruxolitinib Extended-Release Tablets, and believes it may be eligible for first-to-file status in the US, subject to review and determination by the US Food and Drug Administration (FDA).

#Granules India files Paragraph IV certification for Ruxolitinib ER tablets